CA3073129C - Composes pyridinamine-pyridone et pyrimidinamine-pyridone - Google Patents

Composes pyridinamine-pyridone et pyrimidinamine-pyridone

Info

Publication number
CA3073129C
CA3073129C CA3073129A CA3073129A CA3073129C CA 3073129 C CA3073129 C CA 3073129C CA 3073129 A CA3073129 A CA 3073129A CA 3073129 A CA3073129 A CA 3073129A CA 3073129 C CA3073129 C CA 3073129C
Authority
CA
Canada
Prior art keywords
pyridyl
trifluoromethyl
pyridin
phenyl
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3073129A
Other languages
English (en)
Other versions
CA3073129A1 (fr
Inventor
Johan Lindstrom
Rickard FORSBLOM
Tobias GINMAN
Fredrik Rahm
Jenny Viklund
Original Assignee
Sprint Bioscience AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sprint Bioscience AB filed Critical Sprint Bioscience AB
Priority claimed from PCT/EP2018/072790 external-priority patent/WO2019038389A1/fr
Publication of CA3073129A1 publication Critical patent/CA3073129A1/fr
Application granted granted Critical
Publication of CA3073129C publication Critical patent/CA3073129C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne de nouveaux composés pyridinamine-pyridone et pyrimidinamine-pyridone de formule (I), des compositions pharmaceutiques contenant ces composés, et des procédés d'utilisation de tels composés pour le traitement de maladies, notamment le cancer, le diabète de type II, une maladie inflammatoire, des troubles neurodégénératifs, des troubles cardiovasculaires, des maladies auto-immunes et des infections virales ; dans la formule (I), R1, R2, R3 et Z sont tels que définis dans la description.
CA3073129A 2017-08-23 2018-08-23 Composes pyridinamine-pyridone et pyrimidinamine-pyridone Active CA3073129C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17187560.2 2017-08-23
EP17187560 2017-08-23
PCT/EP2018/072790 WO2019038389A1 (fr) 2017-08-23 2018-08-23 Composés pyridinamine-pyridone et pyrimidinamine-pyridone

Publications (2)

Publication Number Publication Date
CA3073129A1 CA3073129A1 (fr) 2019-02-28
CA3073129C true CA3073129C (fr) 2025-09-16

Family

ID=

Similar Documents

Publication Publication Date Title
US11780858B2 (en) Pyridinamine-pyridone and pyrimidinamine-pyridone compounds
AU2023258375A1 (en) Pyridylpyridone Compounds
IL302355A (en) Azaindolylpyridone and diazaindolylpyridone compounds
CA3073129C (fr) Composes pyridinamine-pyridone et pyrimidinamine-pyridone
HK40092606A (en) Pyridinamine-pyridone and pyrimidinamine-pyridone compounds
RU2804638C2 (ru) Пиридинаминпиридоны и пиримидинаминпиридоны
CA3072974C (fr) Composes de pyridylpyridone
CA3072861C (fr) Composes d'azaindolylpyridone et de diazaindolylpyridone
HK40030344B (en) Pyridinamine-pyridone and pyrimidinamine-pyridone compounds
HK40030344A (en) Pyridinamine-pyridone and pyrimidinamine-pyridone compounds
CA3015045C (fr) Composes 6-aryl-4-morpholin-1-yl-pyridone utilises pour le traitement du cancer et du diabete
HK40072566A (en) Azaindolylpyridone and diazaindolylpyridone compounds
HK40079059A (en) Pyridylpyridone compounds